Cencora(COR) - 2025 Q4 - Earnings Call Presentation

Financial Performance - Fiscal Year 2025 - Cencora's revenue increased by 93% year-over-year to $3213 billion[22] - Adjusted diluted earnings per share grew by 163% year-over-year to $1600[21] - Adjusted operating income increased by 158% year-over-year[20] - U S Healthcare Solutions segment operating income increased by 218% year-over-year[20] - International Healthcare Solutions segment operating income declined by 91% year-over-year[20] Q4 Fiscal Year 2025 Performance - Revenue grew by 59% year-over-year[12] - Consolidated adjusted operating income increased by 202% year-over-year[12] - U S Healthcare Solutions segment operating income increased by 251% year-over-year[12] - International Healthcare Solutions segment operating income declined by 20% year-over-year[12] Fiscal Year 2026 Guidance - Revenue is projected to grow by 5% to 7%[25] - Adjusted operating income is expected to grow by 8% to 10%[10] - Adjusted diluted earnings per share are projected to be between $1745 and $1775[25]